319 related articles for article (PubMed ID: 26087071)
1. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study.
Tanner NT; Aggarwal J; Gould MK; Kearney P; Diette G; Vachani A; Fang KC; Silvestri GA
Chest; 2015 Dec; 148(6):1405-1414. PubMed ID: 26087071
[TBL] [Abstract][Full Text] [Related]
2. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
[TBL] [Abstract][Full Text] [Related]
3. Pulmonologists' Reported Use of Guidelines and Shared Decision-making in Evaluation of Pulmonary Nodules: A Qualitative Study.
Wiener RS; Slatore CG; Gillespie C; Clark JA
Chest; 2015 Dec; 148(6):1415-1421. PubMed ID: 25789979
[TBL] [Abstract][Full Text] [Related]
4. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
[TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Patient With a Pulmonary Nodule: A Review.
Mazzone PJ; Lam L
JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
[TBL] [Abstract][Full Text] [Related]
8. Factors that influence physician decision making for indeterminate pulmonary nodules.
Vachani A; Tanner NT; Aggarwal J; Mathews C; Kearney P; Fang KC; Silvestri G; Diette GB
Ann Am Thorac Soc; 2014 Dec; 11(10):1586-91. PubMed ID: 25386795
[TBL] [Abstract][Full Text] [Related]
9. Return of the pulmonary nodule: the radiologist's key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules.
Graham RN; Baldwin DR; Callister ME; Gleeson FV
Br J Radiol; 2016; 89(1059):20150776. PubMed ID: 26781558
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons.
Tanner NT; Brasher PB; Jett J; Silvestri GA
Clin Lung Cancer; 2020 Mar; 21(2):e89-e98. PubMed ID: 31732400
[TBL] [Abstract][Full Text] [Related]
11. PET scanning and the solitary pulmonary nodule.
Fletcher JW
Semin Thorac Cardiovasc Surg; 2002 Jul; 14(3):268-74. PubMed ID: 12232868
[TBL] [Abstract][Full Text] [Related]
12. Coexisting pulmonary nodules in operable lung cancer: prevalence and probability of malignancy.
Ruppert AM; Lerolle U; Carette MF; Lavole A; Khalil A; Bazelly B; Antoine M; Cadranel J; Milleron B
Lung Cancer; 2011 Nov; 74(2):233-8. PubMed ID: 21511355
[TBL] [Abstract][Full Text] [Related]
13. Management of pulmonary nodules in head and neck cancer patients - Our experience and interpretation of the British Thoracic Society Guidelines.
Green R; King M; Reid H; Murchison JT; Evans A; Nixon IJ
Surgeon; 2017 Aug; 15(4):227-230. PubMed ID: 27838234
[TBL] [Abstract][Full Text] [Related]
14. British Thoracic Society guidelines for the investigation and management of pulmonary nodules.
Callister ME; Baldwin DR; Akram AR; Barnard S; Cane P; Draffan J; Franks K; Gleeson F; Graham R; Malhotra P; Prokop M; Rodger K; Subesinghe M; Waller D; Woolhouse I; ;
Thorax; 2015 Aug; 70 Suppl 2():ii1-ii54. PubMed ID: 26082159
[No Abstract] [Full Text] [Related]
15. Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules.
Choi HK; Ghobrial M; Mazzone PJ
Ann Am Thorac Soc; 2018 Oct; 15(10):1117-1126. PubMed ID: 30272500
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
17. Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy.
Reid M; Choi HK; Han X; Wang X; Mukhopadhyay S; Kou L; Ahmad U; Wang X; Mazzone PJ
Chest; 2019 Aug; 156(2):367-375. PubMed ID: 30940455
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and consequences of non-adherence to an evidence-based approach for incidental pulmonary nodules.
Wayne MT; Prescott HC; Arenberg DA
PLoS One; 2022; 17(9):e0274107. PubMed ID: 36084105
[TBL] [Abstract][Full Text] [Related]
19. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm.
Patel VK; Naik SK; Naidich DP; Travis WD; Weingarten JA; Lazzaro R; Gutterman DD; Wentowski C; Grosu HB; Raoof S
Chest; 2013 Mar; 143(3):840-846. PubMed ID: 23460161
[TBL] [Abstract][Full Text] [Related]
20. Management of an incidentally discovered pulmonary nodule.
Beigelman-Aubry C; Hill C; Grenier PA
Eur Radiol; 2007 Feb; 17(2):449-66. PubMed ID: 17021707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
